Flomyst F (250 mcg+10 mcg)/puff (Inhaler)
120 metered doses: ৳ 895.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Fluticasone propionate formoterol fumarate |
| Company | Beximco pharmaceuticals ltd |
| Also available as |
Indications
- Regular treatment of asthma
- Treatment of COPD
- Inhaled corticosteroids
- Long-acting ß2 agonist
- Asthma in adults and adolescents
- COPD in adults
- Use in adolescents aged 12 years and above
- Use in adults only
- Use in children under 12 years
- Not recommended for children less than 12 years of age
Pharmacology
- Pressurised inhalation
- Suspension
- Active ingredients: Fluticasone propionate, Formoterol fumarate dihydrate
- Steroids for reducing swelling and inflammation in the lungs
- Long-acting beta 2 agonists for bronchodilation and improving breathing
- Daily use recommended for improving breathing and preventing asthma symptoms
Dosage
- Training for patients on inhaler use
- Regular reassessment by a doctor
- Titration to lowest effective dose
- Appropriate dosage based on severity of the disease
- Recommended dose for adults and adolescents aged 12 years and above: Two inhalations (puffs) twice daily
- Highest strength for adults only: Fluticasone Propionate 250 mcg & Formoterol Fumarate 10 mcg inhaler- two inhalations (puffs) twice daily
- No data available for use in children under 12 years of age
Administration
- Proper inhaler usage instructions
- Effective inhaler use for preventing and lessening asthma attacks
- Steps for using inhaler correctly according to National Asthma Guidelines
- Instructions for cleaning inhaler
- Importance of checking technique regularly
- Caution for patients with specific medical conditions
Interaction
- No formal drug interaction studies performed
- Fluticasone Propionate as a substrate of CYP 3A4
- Caution advised for co-administration with strong CYP 3A4 inhibitors
Contraindications
- Not for treating acute asthma symptoms
- Prophylactic use not studied in exercise-induced asthma
- Caution in patients with specific infections and medical conditions
- Additional blood sugar controls in diabetic patients
- Possible systemic effects at high doses
Side Effects
- Paradoxical bronchospasm
- Hypersensitivity reactions
- Relief techniques for dysphonia and candidiasis
- Treatment discontinuation and alternative therapy initiation if necessary
Pregnancy & Lactation
- Limited data on use in pregnant women
- Reproductive toxicity in animal studies
- Not recommended during pregnancy
- Decision-making for breastfeeding mothers
- No data available on effects on fertility
Use in Special Populations
- No need to adjust dose in elderly patients
- No data available for hepatic or renal impairment
- Regular monitoring of children's height for prolonged treatment
- No data available for use in children under 12 years of age
Overdose Effects
- No clinical trial data available for overdose
- Potential adverse experiences for Formoterol Fumarate overdose
- Acute overdose effects for Fluticasone Propionate
Therapeutic Class
- Respiratory corticosteroids
Storage Conditions
- Cool and dry place
- Protected from light